WEI LIN (Chief Medical Officer) received a stock award from REVOLUTION MEDICINES, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 3/4/2025ACC: 0001610717-25-000052
Officer· Chief Medical Officer
Since Mar 2026
+52K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
72.80K acquired · 20.80K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−20.80K
Price / share
—
Trade value
—
% of position
18.5%
3/1/2025
112.45K→91.65K
Total
Net shares
−20.80K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/1/2025 | A · Award | −20.80K | — | — | 18.5% | 112.45K | 91.65K |
| Total | −20.80K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
72.80K shares
Shares
+72.80K
Strike price
40.74
Held after
72.80K
Exercisable
—
3/1/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock72.80K shares | 3/1/2025 | A · Award | +72.80K | 40.74 | — | 72.80K |